Suppr超能文献

相似文献

2
Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
Mol Immunol. 2013 Dec;56(4):660-74. doi: 10.1016/j.molimm.2013.05.008. Epub 2013 Aug 2.
3
PK/PD analysis of a novel pH-dependent antigen-binding antibody using a dynamic antibody-antigen binding model.
Drug Metab Pharmacokinet. 2016 Apr;31(2):123-32. doi: 10.1016/j.dmpk.2015.12.007. Epub 2016 Jan 6.
4
Targeting FcRn for the modulation of antibody dynamics.
Mol Immunol. 2015 Oct;67(2 Pt A):131-41. doi: 10.1016/j.molimm.2015.02.007. Epub 2015 Mar 9.
5
Engineered monoclonal antibody with novel antigen-sweeping activity in vivo.
PLoS One. 2013 May 7;8(5):e63236. doi: 10.1371/journal.pone.0063236. Print 2013.
6
pH-dependent binding engineering reveals an FcRn affinity threshold that governs IgG recycling.
J Biol Chem. 2015 Feb 13;290(7):4282-90. doi: 10.1074/jbc.M114.603712. Epub 2014 Dec 23.
7
Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRn.
MAbs. 2017 Oct;9(7):1105-1117. doi: 10.1080/19420862.2017.1359455. Epub 2017 Aug 8.
8
Rapid depletion of "catch-and-release" anti-ASGR1 antibody in vivo.
MAbs. 2024 Jan-Dec;16(1):2383013. doi: 10.1080/19420862.2024.2383013. Epub 2024 Jul 25.
9
Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin.
J Biol Chem. 2017 Aug 11;292(32):13312-13322. doi: 10.1074/jbc.M117.794248. Epub 2017 Jun 21.
10
Intracellular delivery and trafficking dynamics of a lymphoma-targeting antibody-polymer conjugate.
Mol Pharm. 2012 Dec 3;9(12):3506-14. doi: 10.1021/mp300338s. Epub 2012 Nov 5.

引用本文的文献

1
Integrating thermodynamics and molecular kinetics into western blotting teaching.
Front Mol Biosci. 2025 Aug 14;12:1640740. doi: 10.3389/fmolb.2025.1640740. eCollection 2025.
2
Advanced human FcRn knock-in mice for pharmacokinetic profiling of therapeutic antibodies.
Sci Rep. 2025 Jul 26;15(1):27186. doi: 10.1038/s41598-025-11168-7.
3
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress.
BioDrugs. 2025 May;39(3):373-409. doi: 10.1007/s40259-025-00708-2. Epub 2025 Mar 29.
4
Sequence-based engineering of pH-sensitive antibodies for tumor targeting or endosomal recycling applications.
MAbs. 2024 Jan-Dec;16(1):2404064. doi: 10.1080/19420862.2024.2404064. Epub 2024 Sep 17.
5
Reduction of circulating IgE and allergens by a pH-sensitive antibody with enhanced FcγRIIb binding.
Mol Ther. 2024 Oct 2;32(10):3729-3742. doi: 10.1016/j.ymthe.2024.08.029. Epub 2024 Sep 2.
6
Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling.
Structure. 2024 Sep 5;32(9):1404-1418.e7. doi: 10.1016/j.str.2024.07.014. Epub 2024 Aug 14.
7
Rapid depletion of "catch-and-release" anti-ASGR1 antibody in vivo.
MAbs. 2024 Jan-Dec;16(1):2383013. doi: 10.1080/19420862.2024.2383013. Epub 2024 Jul 25.
8
A high-throughput lysosome trafficking assay guides ligand selection and elucidates differences in CD22-targeted nanodelivery.
Sci Technol Adv Mater. 2024 May 13;25(1):2351791. doi: 10.1080/14686996.2024.2351791. eCollection 2024.
9
Engineered therapeutic antibodies with mannose 6-phosphate analogues as a tool to degrade extracellular proteins.
Front Immunol. 2024 Mar 12;15:1273280. doi: 10.3389/fimmu.2024.1273280. eCollection 2024.
10
Extracellular targeted protein degradation: an emerging modality for drug discovery.
Nat Rev Drug Discov. 2024 Feb;23(2):126-140. doi: 10.1038/s41573-023-00833-z. Epub 2023 Dec 7.

本文引用的文献

1
Engineered monoclonal antibody with novel antigen-sweeping activity in vivo.
PLoS One. 2013 May 7;8(5):e63236. doi: 10.1371/journal.pone.0063236. Print 2013.
2
Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9.
J Biol Chem. 2012 Mar 30;287(14):11090-7. doi: 10.1074/jbc.M111.319764. Epub 2012 Jan 31.
3
Therapeutic targeting of the interleukin-6 receptor.
Annu Rev Pharmacol Toxicol. 2012;52:199-219. doi: 10.1146/annurev-pharmtox-010611-134715. Epub 2011 Sep 9.
4
A combinatorial histidine scanning library approach to engineer highly pH-dependent protein switches.
Protein Sci. 2011 Sep;20(9):1619-31. doi: 10.1002/pro.696. Epub 2011 Aug 3.
7
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization.
Nat Biotechnol. 2010 Nov;28(11):1203-7. doi: 10.1038/nbt.1691. Epub 2010 Oct 17.
8
Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease.
J Clin Oncol. 2010 Aug 10;28(23):3701-8. doi: 10.1200/JCO.2009.27.2377. Epub 2010 Jul 12.
9
Therapeutic antibodies for autoimmunity and inflammation.
Nat Rev Immunol. 2010 May;10(5):301-16. doi: 10.1038/nri2761.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验